Tetrahydrobiopterin in the prevention of hypertonia in hypoxic fetal brain

Authors:

Abstract
Objective: Tetrahydrobiopterin (BH4) deficiency is a cause of dystonia at birth. We hypothesized that BH4is a developmental factor determining vulnerability of the immature fetal brain to hypoxic‐ischemic injury and subsequent motor deficits in newborns.Methods: Pregnant rabbits were subjected to 40‐minute uterine ischemia, and fetal brains were investigated for global and focal changes in BH4. Newborn kits were assessed by neurobehavioral tests following vehicle and sepiapterin (BH4analog) treatment of dams.Results: Naive fetal brains at 70% gestation (E22) were severely deficient for BH4compared with maternal and other fetal tissues. BH4concentration rapidly increased normally in the perinatal period, with the highest concentrations found in the thalamus compared with basal ganglia, frontal, occipital, hippocampus, and parietal cortex. Global sustained 40‐minute hypoxia‐ischemia depleted BH4in E22 thalamus and to a lesser extent in basal ganglia, but not in the frontal, occipital, and parietal regions. Maternal supplementation prior to hypoxia‐ischemia with sepiapterin increased BH4in all brain regions and especially in the thalamus, but did not increase the intermediary metabolite, 7,8‐BH2. Sepiapterin treatment also reduced incidence of severe motor deficits and perinatal death following E22 hypoxia‐ischemia.Interpretation: We conclude that early developmental BH4deficiency plays a critical role in hypoxic‐ischemic brain injury. Increasing brain BH4via maternal supplementation may be an effective strategy in preventing motor deficits from antenatal hypoxia‐ischemia. Ann Neurol 2009;66:323–331

This publication has 26 references indexed in Scilit: